| Literature DB >> 29415687 |
Helen Quirk1, Cris Glazebrook2, Holly Blake3.
Abstract
BACKGROUND: This study describes the development and feasibility evaluation of a physical activity intervention for children with type 1 diabetes called 'Steps to Active Kids with Diabetes' (STAK-D). It aims to explore the feasibility and acceptability of the intervention and study design.Entities:
Keywords: Children; Feasibility study; Intervention; Paediatric diabetes; Physical activity; Process evaluation; Self-efficacy; Type 1 diabetes
Mesh:
Year: 2018 PMID: 29415687 PMCID: PMC5804086 DOI: 10.1186/s12887-018-1036-8
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
STAK-D programme content and theoretical underpinning
| Weeks | Intervention content | Theoretical underpinning |
|---|---|---|
| 1–6 | Activity diary for children: physical activity advice for children with T1DM, recommendations (five ‘pieces’ of activity a day), safety information, physical activity log and step-count diary. | Knowledge |
| 1–6 | Pedometer: tool to promote goal-setting and self-monitoring. | Self-regulation (self-monitoring and goal setting) |
| 1–6 | STAK street dance DVD: developed for the original STAK programme [ | Vicarious reinforcement (role models) |
| 1–6 | Group activity sessions: circuit training-style group activity session in a leisure room situated in the hospital supervised by STAK-D volunteers. Children given option to bring friend/sibling. | Vicarious reinforcement |
| 1, 3, 6 | Motivational Interview (MI) and goal-setting: 1:1 session with the researcher at the child’s home to explore children’s perceptions and understanding of physical activity, readiness to change and goal-setting. | Readiness to change |
| 1–6 | Parents' Booklet: physical activity advice for safe participation aiming to educate and encourage parental involvement. | Social support |
Fig. 1Flowchart of participants through the feasibility trial
Participant characteristics at baseline
| Outcome | Intervention | Control |
|---|---|---|
| Total (n) | 8 | 5 |
| Gender (n (%)) | Male = 2 (25) | Male = 5 (100) |
| Female = 6 (75) | Female = 0 (0) | |
| Age (Mean (SD)) | 10.13 (.84) | 10.00 (1.00) |
| Length of diagnosis in months (Mean (SD)) | 61.13 (37.29) | 34.80 (27.77) |
| HbA1c (mmol/mol) (Mean (SD)) | 57.13 (10.25) | 55.40 (11.78) |
| BMI (kg/m2) (Mean (SD)) | 19.51 (3.79) | 20.49 (3.36) |
Physical activity and self-efficacy scores and change in scores over time
| Outcome | Group | T1 | T2 | T3 | T1-T2 | T1-T3 | |||
|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | n | Mean (SD) | n | Mean (SD) | n | Difference (95% CI) | Difference (95% CI) | ||
| Accelerometer MVPA (mins) | Whole | 84.82 (26.94) | 11 | 69.46 (24.16) | 8 | - | - | −15.36 (−40.68, 9.96) | - |
| INT | 83.59 (27.25) | 7 | 66.15 (18.67) | 4 | - | - | −17.44 (−52.49, 17.61) | - | |
| CONT | 86.98 (30.42) | 4 | 72.78 (31.38) | 4 | - | - | −14.20 (−67.67, 39.27) | - | |
| Self-reported physical activity | Whole | 54.10 (8.47) | 13 | 49.63 (5.01) | 8 | 54.30 (7.86) | 10 | −4.47 (−11.42, 2.48) | 0.20 (−6.99,7.39) |
| INT | 56.78 (9.10) | 8 | 52.00 (5.42) | 4 | 58.80 (7.46) | 5 | −4.78 (−15.93, 6.37) | 2.02 (−8.70, 12.74) | |
| CONT | 49.80 (5.72) | 5 | 47.25 (3.77) | 4 | 49.80 (5.72) | 5 | −2.55 (−10.45, 5.35) | 0.00 (−8.34, 8.34) | |
| Self-efficacy Total | Whole | 60.82 (7.10) | 11 | 58.88 (9.49) | 8 | 58.80 (9.14) | 10 | −1.94 (− 9.95, 6.07) | −2.02 (−9.46, 5.42) |
| INT | 61.71 (5.71) | 7 | 63.50 (4.65) | 4 | 58.60 (9.81) | 5 | 1.79 (−5.84, 9.42) | −3.11 (−13.05, 6.83) | |
| CONT | 59.25 (9.88) | 4 | 54.25 (11.47) | 4 | 59.00 (9.57) | 5 | −5.00 (−23.52, 13.52) | −0.25 (−15.64, 15.14) | |
| Self-efficacy Adequacy | Whole | 21.55 (3.11) | 11 | 21.63 (3.78) | 8 | 21.40 (3.44) | 10 | 0.08 (−3.83, 3.99) | −0.15 (−3.64, 3.34) |
| INT | 22.43 (1.81) | 7 | 23.50 (2.38) | 4 | 21.60 (3.97) | 5 | 1.07 (−1.79, 3.93) | −0.83 (−4.58, 2.92) | |
| CONT | 20.00 (4.55) | 4 | 19.75 (4.27) | 4 | 21.20 (3.27) | 5 | −0.25 (−7.88, 7.38) | 1.20 (−4.94, 7.34) | |
| Self-efficacy Predilection | Whole | 28.82 (4.12) | 11 | 27.25 (4.80) | 8 | 27.50 (5.28) | 10 | −1.57 (−5.90, 2.76) | −1.32 (−4.31, 1.67) |
| INT | 28.71 (3.99) | 7 | 29.25 (2.75) | 4 | 27.80 (5.36) | 5 | 0.54 (−4.60, 5.68) | −0.91 (−6.89, 5.07) | |
| CONT | 29.00 (4.97) | 4 | 25.25 (5.97) | 4 | 27.20 (5.81) | 5 | −3.75 (−13.25, 5.75) | −1.80 (−10.37, 6.97) | |
| Self-efficacy Enjoyment | Whole | 10.45 (1.57) | 11 | 10.00 (2.07) | 8 | 9.90 (1.91) | 10 | −0.45 (−2.21, 1.31) | −0.55 (−2.14, 1.04) |
| INT | 10.57 (1.72) | 7 | 10.75 (1.50) | 4 | 9.20 (2.17) | 5 | 0.18 (−2.16, 2.52) | −1.37 (−3.87, 1.13) | |
| CONT | 10.25 (1.50) | 4 | 9.25 (2.50) | 4 | 10.60 (1.52) | 5 | −1.00 (−4.57, 2.57) | 0.35 (−2.05, 2.75) | |
CI confidence interval, CONT control group, INT intervention group, MVPA moderate-to-vigorous physical activity, SD standard deviation